Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesControversies in the management of vesicoureteral reflux: The rationale for the RIVUR study
Journal of Pediatric Urology , 09/11/09
Mathews R et al. – There are far reaching consequences of the results of the RIVUR Study. If antibiotic prophylaxis does not prevent UTI in children with VUR, or lead to reduction in renal scarring, does identification of VUR provide any benefits? Perhaps appropriate treatment of UTI may be all that is necessary for preserving renal function.
Related Articles
Predictive Factors for Vesicoureteral Reflux and Prenatally Diagnosed Renal Pelvic Dilatation
The Journal of Urology, 10/29/09
Relevance Score: 69%
Abnormal renal scans and decreased early resolution of low grade vesicoureteral reflux
International Braz J Urol, 11/04/09
Relevance Score: 68%
Nomograms for Predicting Annual Resolution Rate of Primary Vesicoureteral Reflux: Results From 2,462 Children
The Journal of Urology, 10/01/09
Relevance Score: 68%
Diagnosis and management of vesicoureteral reflux in children
NCP Urology, 10/06/09
Relevance Score: 67%
Change of Urodynamic Patterns in Infants With Dilating Vesicoureteral Reflux: 3-Year Followup
The Journal of Urology, 10/30/09
Relevance Score: 66%
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
A Round Table Discussion: Case Studies of Patients with Lower Urinary Tract Symptoms
Urologic Clinics of North America, 12/04/09
A longitudinal investigation of the impact of typology of urinary incontinence on quality of life during midlife
Maturitas, 12/04/09
Cizolirtine Citrate Is Safe and Effective for Treating Urinary Incontinence Secondary to Overactive Bladder: A Phase 2 Proof-of-Concept Study
European Urology, 12/03/09
Article Search
Sponsor